Head-to-head
CoreAge Rx vs Found
CoreAge Rx and Found both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxFound
Ranked #20 · Grade C
Best for: Working moms who want an FDA-approved brand pen with insurance actually navigated for them, or one flat compounded price that covers either molecule — and who will read which of the two plans they've been put on.
Visit FoundThe verdict
CoreAge Rx edges out Found on the Rx-Readiness Score, 95 to 71 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Found is still a genuine option — the insurance-and-brand specialist: real Wegovy and Zepbound access with the paperwork handled, one flat compounded price for either molecule, and an oral pill — priced by plan, billed every four weeks, and thin on state disclosure. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Found |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 71/100 · C |
| Overall rank | #1 | #20 |
| Semaglutide | $149/mo | $299/mo |
| Tirzepatide | $349/mo | $299/mo |
| Coverage | All 50 states | Not disclosed (California shows no available plans) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Found
Ranked #20 · Grade C
What we like
- Genuine brand-name access — Wegovy, Zepbound, Ozempic and Mounjaro — with insurance navigation done for you
- One flat compounded price at every dose, and the same price whether you're on semaglutide or tirzepatide
- An oral option (Foundayo) for anyone avoiding injections, plus a Medicare bridge programme
The caveats
- Two plan types that are easy to confuse — the compounded plan includes medication, the branded plan does not, and that mix-up shows up in its own complaint record
- Billed every 4 weeks, so 13 charges a year rather than 12
- Total state coverage isn't disclosed, and California shows no available plans
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Found against other providers on our shortlist.
Or browse the full comparison hub.